Aplagon
PrivateLast Round
Series A
Feb 3, 2025
Total Funding Raised
$9.42M
Momentum Score
50 /100
Company Overview
Aplagon is a clinical-stage biopharmaceutical company that develops first-in-class therapeutics for thromboinflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aplagon Comps
Public and private peers based on sector, stage, and business model.
Aplagon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 3, 2025 | ||||
| Grant | Nov 16, 2022 | ||||
| VC Round | May 28, 2021 | ||||
| Seed | Dec 7, 2018 |
Aplagon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| Innovestor | Series A, Seed |
| Helsinki University Funds | Seed |
| Invesdor | VC Round |
| Fåhraeus Startup and Growth | Series A |
| Finnvera | Seed |
| Jenny and Antti Wihuri Foundation | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Monthly visitors grew 98% MoM.
- Jun 1, 2025
Monthly visitors grew 159% MoM, reaching 1K.
Aplagon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aplagon's valuation, stock price, and market status.
